- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Naked eye.
Displaying page 1 of 1.
EudraCT Number: 2013-005565-40 | Sponsor Protocol Number: OTP-B-Linköping | Start Date*: 2014-09-11 |
Sponsor Name:Department of Biomedical Engineering, Linköping University | ||
Full Title: Optical measurement with 5-ALA during surgical resection of brain tumors in children | ||
Medical condition: Tumour border by means of fluorescenstechnique during surgical resection of brain tumours. | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-000845-64 | Sponsor Protocol Number: CCR4085 | Start Date*: 2014-12-17 | |||||||||||
Sponsor Name:The Royal Marsden NHS Foundation Trust | |||||||||||||
Full Title: A multicentre randomised phase II study of aflibercept plus chemotherapy in patients with colorectal liver-only metastases deemed to be inoperable or unsuitable for upfront liver resection | |||||||||||||
Medical condition: colorectal cancer with liver metastases | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004037-32 | Sponsor Protocol Number: Lmax-microscopy-Bcn | Start Date*: 2014-04-10 | |||||||||||
Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | |||||||||||||
Full Title: Characterisation of maximum lesion count during treatment (Lmax) by non-invasive study with high definition optical coherence tomography (HD-OCT) and reflectance confocal microscopy (RCM) | |||||||||||||
Medical condition: actinic keratosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004259-37 | Sponsor Protocol Number: CASM981CDE20 | Start Date*: 2005-12-16 | |||||||||||
Sponsor Name:Novartis Pharma GmbH | |||||||||||||
Full Title: An uncontrolled, multicenter 12 month long term study on skin reconstitution with Elidel® (pimecrolimus) 1% cream in adult patients with atopic eczema and corticosteroid induced skin damage | |||||||||||||
Medical condition: atopic eczema | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-004579-16 | Sponsor Protocol Number: FU-04-21 | Start Date*: 2022-01-18 | |||||||||||
Sponsor Name:Adamed Pharma S.A. | |||||||||||||
Full Title: A Phase II, Randomized, Parallel design, Open label, Dose ranging Study to evaluate the efficacy and safety of Furazidin vaginal tablets in women with bacterial vaginosis | |||||||||||||
Medical condition: Bacterial Vaginosis (BV) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: PL (Completed) HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001849-15 | Sponsor Protocol Number: IFCT-1601 | Start Date*: 2016-08-10 | ||||||||||||||||
Sponsor Name:IFCT | ||||||||||||||||||
Full Title: A PHASE II PROSPECTIVE IMMUNE NEOADJUVANT THERAPY STUDY OF DURVALUMAB (MEDI4736) IN EARLY STAGE NON-SMALL CELL LUNG CANCER | ||||||||||||||||||
Medical condition: Stage IB (> 4 cm), II Non Small Cell Lung Cancer resectable | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-004119-35 | Sponsor Protocol Number: 14I-BMT09 | Start Date*: 2015-03-03 | ||||||||||||||||
Sponsor Name:IBSA Institut Biochimique SA | ||||||||||||||||||
Full Title: Multicentre, prospective, double-blind, in parallel groups, randomized, placebo-controlled clinical trial to evaluate the short-term efficacy and safety of Betamethasone valerate 2.25 mg medicated ... | ||||||||||||||||||
Medical condition: Chronic Lateral Elbow Tendinopathy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
